Remove Doctor Remove Pharma Companies Remove Pharmacy Remove Regulation
article thumbnail

The social media problem for healthcare

World of DTC Marketing

A year ago, Facebook was making a hard charge to get the pharma business. From my estimates, most of it failed because pharma companies are afraid of misinformation concerning regulations around DTC marketing. Spots for Amazon Pharmacy were found on over 30 health misinformation sites. Bob Hoffman.

Branding 224
article thumbnail

Disruption in healthcare is coming

World of DTC Marketing

PBMs, insurers, pharma companies, and hospitals don’t want to give up their profits even if it’s better for the general population. The company has hired former senior health regulators to help it navigate America’s healthcare bureaucracy. . Google is also giving health records another whirl.

Pharmacy 227
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

COVID-19 and the digital pharma marketing revolution

pharmaphorum

The global pandemic has caused pharma companies to invest in digital marketing, as healthcare systems across the world adapt to strict lockdown rules. Healthcare companies have been in the vanguard of this change, with an enormous rise in the use of telehealth and all forms of digital communications.

article thumbnail

Hollywood and the Metaverse’s effect on pharma’s content

pharmaphorum

Gaurav Kapoor, co-founder and executive vice president of Indegene, tells pharmaphorum how pharma can take lessons from the entertainment industry and prepare for the Metaverse to enhance content engagement. Pharma companies’ customer communication methods require reimagining as technology progresses.

Branding 115
article thumbnail

To help solve patient distrust in pharma, industry collaboration is key

pharmaphorum

Pharma companies are now household names, having been thrust into the public’s consciousness after dominating the headlines through the pandemic. It is a pertinent case of what could limit pharma’s future growth and highlights resistance to a future in which pharmaceutical companies take up a greater share of patient care.

article thumbnail

Drug development and working with specialised Rare Disease networks

pharmaphorum

Additionally, the work being done within Rare Disease networks, formed of specialty sites, pharma companies, CROs, researchers, and other stakeholders, can all benefit from the value generated by real world genomic data, as outlined by panellist Dr Joanne Hackett, Head of Genomic and Precision medicine at IQVIA. Headway being made.

article thumbnail

A history of the pharmaceutical industry

pharmaphorum

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. Merck in Germany was possibly the earliest company to move in this direction. Thalidomide and the development of drug safety regulation and monitoring. pharmaphorum looks at its evolution over the centuries.

Medicine 145